{
    "2019-05-06": [
        [
            {
                "time": "",
                "original_text": "又一家国产PD-1单抗传获批 抗癌神药大战即将揭幕？",
                "features": {
                    "keywords": [
                        "国产PD-1单抗",
                        "抗癌神药",
                        "获批"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【平安医药】医药行业2018年年报及2019年一季报综述：2018Q4利润增速承压，医药子行业持续分化",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2018年年报",
                        "2019年一季报",
                        "利润增速承压",
                        "医药子行业分化"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "最新药审动态：复星又来重磅抗癌生物类似药 3个亿级产品通过评",
                "features": {
                    "keywords": [
                        "药审动态",
                        "复星",
                        "抗癌生物类似药",
                        "亿级产品",
                        "通过评"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "2019年第一季度，5家药企净利润超过10亿元",
                "features": {
                    "keywords": [
                        "2019年第一季度",
                        "药企",
                        "净利润",
                        "超过10亿元"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}